SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K, dated August 6, 2025, serves as a current report for National Health Investors Inc. The filing announces the release of earnings results for the quarter ended June 30, 2025. The company is incorporated in Maryland and trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These financial metrics are contained within the press release filed as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It solely references the issuance of the Second Quarter Earnings Press Release for the period ended June 30, 2025.
Guidance, Outlook, and Risks
The text of this 8-K does not contain management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. Such information is expected to be found in the referenced Exhibit 99.1 press release.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures in the Second Quarter Earnings Press Release (Exhibit 99.1).
- Confirm the company's liquidity position and debt levels as reported in the full earnings release.
- Review management's commentary on the outlook for the remainder of 2025 in the referenced press release.
- Note that the filing was signed by John L. Spaid, Chief Financial Officer, on August 6, 2025.